|
|
|
Insider
Information: |
Oboyle Kevin C |
Relationship: |
|
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
267,712 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$543,963 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
267,712 |
|
|
Total
Value |
$543,963 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
36.3%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Nuvasive Inc |
NUVA |
CFO and Executive VP |
2009-12-15 |
3,338 |
|
0 |
Premium* |
|
Wright Medical Group N.V |
WMGI |
Director |
2020-11-11 |
0 |
2011-05-12 |
0 |
Premium* |
|
Genmark Diagnostics, Inc. |
GNMK |
Director |
2021-04-22 |
0 |
2012-06-06 |
0 |
Premium* |
|
Durata Therapeutics, Inc. |
DRTX |
Director |
2014-11-17 |
0 |
2012-07-19 |
0 |
Premium* |
|
Zeltiq Aesthetics Inc |
ZLTQ |
Director |
2017-04-28 |
0 |
2014-03-04 |
0 |
Premium* |
|
Sientra, Inc. |
SIEN |
Director |
2022-06-09 |
220,978 |
2016-06-23 |
0 |
Premium* |
|
Nevro Corp |
NVRO |
|
2024-05-23 |
43,396 |
2019-03-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
215 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 9
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ZLTQ |
Zeltiq Aesthetics Inc |
Director |
|
2014-07-30 |
4 |
OE |
$6.03 |
$30,150 |
D/D |
5,000 |
5,000 |
0 |
- |
|
ZLTQ |
Zeltiq Aesthetics Inc |
Director |
|
2014-09-02 |
4 |
OE |
$6.03 |
$30,150 |
D/D |
5,000 |
5,000 |
0 |
- |
|
ZLTQ |
Zeltiq Aesthetics Inc |
Director |
|
2014-09-11 |
4 |
OE |
$6.03 |
$30,150 |
D/D |
5,000 |
5,000 |
0 |
- |
|
ZLTQ |
Zeltiq Aesthetics Inc |
Director |
|
2015-06-26 |
4 |
OE |
$6.03 |
$4,824 |
D/D |
800 |
5,796 |
0 |
- |
|
ZLTQ |
Zeltiq Aesthetics Inc |
Director |
|
2015-07-24 |
4 |
OE |
$6.03 |
$23,517 |
D/D |
3,900 |
9,686 |
0 |
- |
|
ZLTQ |
Zeltiq Aesthetics Inc |
Director |
|
2015-07-31 |
4 |
OE |
$6.03 |
$47,034 |
D/D |
7,800 |
13,586 |
0 |
- |
|
ZLTQ |
Zeltiq Aesthetics Inc |
Director |
|
2016-09-15 |
4 |
OE |
$6.34 |
$47,550 |
D/D |
7,500 |
19,485 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
Director |
|
2019-08-15 |
4 |
D |
$6.42 |
$258,309 |
D/D |
(40,235) |
88,777 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
Director |
|
2019-08-15 |
4 |
AS |
$6.51 |
$14,322 |
D/D |
(2,200) |
102,112 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
Director |
|
2019-08-16 |
4 |
AS |
$6.51 |
$105,137 |
D/D |
(16,150) |
85,962 |
0 |
- |
|
SIEN |
Sientra, Inc. |
Director |
|
2016-06-23 |
4 |
A |
$6.69 |
$125,003 |
D/D |
18,685 |
18,685 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
Director |
|
2015-11-03 |
4 |
B |
$6.71 |
$30,195 |
D/D |
4,500 |
47,798 |
2.39 |
- |
|
DRTX |
Durata Therapeutics, Inc. |
Director |
|
2012-07-19 |
5 |
B |
$9.00 |
$45,000 |
D/D |
5,000 |
5,000 |
0 |
- |
|
NUVA |
Nuvasive Inc |
VP, Finance and CFO |
|
2004-12-15 |
4 |
AS |
$9.49 |
$113,920 |
D/D |
(12,000) |
43,333 |
|
- |
|
NUVA |
Nuvasive Inc |
CFO and Executive VP |
|
2008-10-14 |
4 |
OE |
$9.50 |
$156,750 |
D/D |
16,500 |
19,313 |
0 |
- |
|
NUVA |
Nuvasive Inc |
CFO and Executive VP |
|
2008-11-14 |
4 |
OE |
$9.50 |
$213,442 |
D/D |
16,500 |
9,248 |
0 |
- |
|
NUVA |
Nuvasive Inc |
CFO and Executive VP |
|
2009-09-11 |
4 |
OE |
$9.50 |
$100,149 |
D/D |
10,542 |
4,380 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
Director |
|
2014-09-16 |
4 |
AS |
$9.57 |
$2,507 |
D/D |
(262) |
35,985 |
0 |
- |
|
SIEN |
Sientra, Inc. |
Director |
|
2017-06-22 |
4 |
A |
$9.72 |
$125,009 |
D/D |
12,861 |
31,546 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
Director |
|
2014-05-29 |
4 |
AS |
$10.98 |
$17,593 |
D/D |
(1,603) |
30,174 |
0 |
- |
|
NUVA |
Nuvasive Inc |
CFO and Executive VP |
|
2005-01-14 |
4 |
AS |
$11.00 |
$55,000 |
D/D |
(5,000) |
43,333 |
|
- |
|
GNMK |
Genmark Diagnostics, Inc. |
Director |
|
2014-06-11 |
4 |
AS |
$11.64 |
$3,166 |
D/D |
(272) |
36,247 |
0 |
- |
|
NUVA |
Nuvasive Inc |
CFO and Executive VP |
|
2005-03-14 |
4 |
AS |
$12.40 |
$62,000 |
D/D |
(5,000) |
43,333 |
|
- |
|
GNMK |
Genmark Diagnostics, Inc. |
Director |
|
2014-12-16 |
4 |
AS |
$12.40 |
$3,608 |
D/D |
(291) |
35,694 |
0 |
- |
|
NUVA |
Nuvasive Inc |
CFO and Executive VP |
|
2005-04-14 |
4 |
AS |
$12.48 |
$62,400 |
D/D |
(5,000) |
43,333 |
|
- |
|
215 Records found
|
|
Page 4 of 9 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|